Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mireya Velasquez

St. Jude Children's Research Hospital

United States

Research Interests

Explore related searches

Articles (20)

Collaborators (4)

Thomas Pfeiffer

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

Bilal Omer

Associate Professor

Baylor College of Medicine

UNITED STATES

Esther Obeng

Associate Professor

Emory University

UNITED STATES

Challice Bonifant

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mireya Velasquez

Research Interests

Explore related searches

Articles (20)

Collaborators (4)

Thomas Pfeiffer

Bilal Omer

Esther Obeng

Challice Bonifant

Make your next move.

Mireya Velasquez

Research Interests

Explore related searches

Articles (20)

Single-cell profiling of CD19-directed CAR T-cell phenotypes and immune system dynamics in pediatric B-cell acute lymphoblastic leukemia

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Alternative activation sensing and signal transduction states define CD7 negative T cell function

An AML-associated mutation in DNMT3A gives rise to hyperactive T cells with alloimmune and anti-leukemic activity

B7-H3-CAR T cells expressing 41BB ligand for pediatric solid tumors: Preliminary results of a phase 1 study

Dnmt3a-mutant hematopoietic stem cells generate alloreactive T cells with graft vs host disease and graft vs

Reprogramming the Myeloid Tumor Microenvironment with CD123 CAR T Cells Enhances B7-H3 CAR T Cell Therapy in DIPG

Single-cell profiling of CAR-T CD19 cell phenotypes and immune system dynamics in pediatric BCP-ALL

<i>Dnmt3a</i> Mutant Hematopoietic Stem Cells Produce Hyperactive T Cells with Increased Alloimmune and Anti-Leukemic Activity

Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?

Memory T-Cell Add Back and<i> Prophylactic</i> blinatumomab Post Tcra9 Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial

Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity

Protocol Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cells

Allogeneic CD7-CAR T cells to bridge the gap?

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells

GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells

Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia

Improving the anti-acute myeloid leukemia activity of CD123-specific Engager T cells by MyD88 and CD40 costimulation.

Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML.

Collaborators (4)

Thomas Pfeiffer

Bilal Omer

Esther Obeng

Challice Bonifant

Make your next move.